Correction of inflammation signs in postmenopausal women with the metabolic syndrome
DOI:
https://doi.org/10.24959/nphj.14.1947Keywords:
metabolic syndrome, menopause, treatment, inflammationAbstract
The metabolic syndrome is a common condition that predisposes individuals to the risk of developing cardiovascular diseases and type 2 diabetes. Menopause is known to be associated with a fall in the estrogen levels accompanied with many health changes. Changes in the hormone levels in menopause, in particular estrogen deficiency are associated with increase in the body fat. Additionally, it sounds an alarm for women’s health since it leads to elevated blood pressure, insulin resistance and dyslipidemia. These changes may contribute to increased risks of the metabolic syndrome (MetS) in menopause women. Obesity shares the presence of an inflammatory component with most chronic diseases, it accounts for development of the metabolic disease and other associated health alterations. The aim of the study was to study the effect of bioflavonoid Quercetin and ω-3 PUFA on some components of inflammation in menopausal women with MetS. Material and methods. Eighty menopausal women with MetS were observed. All participants were divided into four groups: group І – basic therapy (20 patients); group ІІ (19 patients) – basic therapy + Quercetin; group ІІІ (21 patients) – basic therapy + ω-3 PUFA; group IV (20 patients) – basic therapy + ω-3 PUFA + Quercetin. The general white blood count in the blood and their subpopulations has been determined; the leukocytal indexes and the degree of endogenous intoxication have been calculated by the erythrocytes sorptivity (ES) test. Results. The use of Quercetin has shown the most significant results for dynamics of white blood cells count, its subpopulations in the blood, leukocytal indexes and the degree of endogenous intoxication. Conclusions. Thus, the additional use of Quercetin has a strong influence on the components of chronic inflammation in the metabolic syndrome in menopausal women.
References
Тогайбаев А.А., Кургузкин А.В., Рикун И.В., Карибжанова Р.М. // Лабораторное дело. – 1988. – №9. – С. 22-24.
Alberti K., Zimmet P., Shaw J. // Diabet. Med. – 2006. – Vol. 6 (5). – P.469-480.
Athsma F., Bartelink M.L., Grobbee D.E., Van Der Schouw // Menopause. – 2006. – Vol. 13(2). – P. 265-279.
Bittner V. // J. Am. Coll. Cardiol. – 2005. – Vol. 46. – P. 1628-1635.
Ford E.S. // Diabet. Care. – 2005. – Vol. 28. – P. 1769-1778.
Giordano D., Corrado F., Santamaria A. et al. // Menopause. – 2011. – Vol. 18 (1). – P. 102-104.
Hidalgo L.A., Chedraui P.A., Morocho N. et al. // Gynecol. Endocrinol. – 2006. – Vol. 22 (8). – P. 447-454.
Rossi R., Nuzzo A., Origliani G., Modena M. // Hypertension. – 2008. – Vol. 6. – P. 865-872.
Schubert C.M., Rogers N.L., Remsberg K.E. et al. // Int. J. Obes. – 2006. –Vol. 30. – P. 251-260.
The Women’s Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial // JAMA. – 2004. – Vol. 291. – P. 1701-1712.
Wellons M., Ouyang P., Schreiner P.J. et al. // Menopause. – 2012. – Vol. 19 (10). – P. 1081-1087.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
